Update on Antisocial Personality Disorder.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing literature without systematic review methodology
PubMed 39230801 · doi:10.1007/s11920-024-01528-x
What was done
This narrative review summarizes recent clinical and translational research on antisocial personality disorder (ASPD). It covers diagnostic controversies regarding the DSM-5 Section III Alternative Model, biological aging findings, heritability and neuroimaging correlates, and emerging pharmacological and psychotherapeutic treatment approaches.
What was found
The abstract reports no numerical findings or statistical effect sizes. Qualitatively, it notes that ASPD is highly heritable with molecular and cortical imaging correlates, that affected individuals age faster than non-antisocial peers, that symptom severity generally declines with age, and that mentalization-based therapy and cognitive-behavioral therapy are undergoing active study.
Why it matters
It provides a concise summary of current diagnostic debates and biological findings in ASPD, underscoring the lack of specific diagnostic tests and the clinical emphasis on treating co-occurring disorders.
Limits
As a narrative review, it lacks systematic search criteria, quality appraisal of included studies, and quantitative data synthesis. Specific sample sizes, effect sizes, and precise treatment efficacy metrics are not reported in the abstract.
Cited by
- supports Sociopath is not an official medical diagnosis in the DSM, but rather a colloquial term for antisocial personality disorder.